The stock of ConforMIS Inc (NASDAQ:CFMS) is a huge mover today! About 142,913 shares traded hands. ConforMIS Inc (NASDAQ:CFMS) has declined 9.33% since March 15, 2016 and is downtrending. It has underperformed by 14.82% the S&P500.
The move comes after 7 months positive chart setup for the $391.50M company. It was reported on Oct, 18 by Barchart.com. We have $12.81 PT which if reached, will make NASDAQ:CFMS worth $164.43 million more.
Analysts await ConforMIS Inc (NASDAQ:CFMS) to report earnings on November, 7. They expect $-0.35 earnings per share, up 22.22% or $0.10 from last year’s $-0.45 per share. After $-0.34 actual earnings per share reported by ConforMIS Inc for the previous quarter, Wall Street now forecasts 2.94% negative EPS growth.
ConforMIS Inc (NASDAQ:CFMS) Ratings Coverage
Out of 9 analysts covering ConforMIS Inc (NASDAQ:CFMS), 7 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 78% are positive. ConforMIS Inc has been the topic of 16 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The rating was maintained by Oppenheimer on Wednesday, August 12 with “Outperform”. JP Morgan initiated the stock with “Overweight” rating in Monday, July 27 report. The rating was maintained by Canaccord Genuity on Tuesday, December 8 with “Buy”. JP Morgan maintained the stock with “Neutral” rating in Tuesday, August 9 report. Oppenheimer initiated ConforMIS Inc (NASDAQ:CFMS) rating on Monday, July 27. Oppenheimer has “Outperform” rating and $26 price target. The firm has “Buy” rating by B. Riley & Co given on Friday, September 16. As per Monday, July 27, the company rating was initiated by Deutsche Bank. The rating was initiated by Sterne Agee CRT on Tuesday, December 1 with “Buy”. The stock of ConforMIS Inc (NASDAQ:CFMS) earned “Buy” rating by Deutsche Bank on Friday, May 13. JP Morgan downgraded it to “Neutral” rating and $8 target price in Friday, May 13 report.
According to Zacks Investment Research, “ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company’s iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The Company serves orthopedic surgeons, hospitals and other medical facilities and patients. ConforMIS, Inc. is based in Bedford, United States.”
More notable recent ConforMIS Inc (NASDAQ:CFMS) news were published by: Streetinsider.com which released: “ConforMIS Inc (CFMS) Announces Publication of Positive iTotal CR Implant Data” on October 17, 2016, also Marketwatch.com with their article: “/quotes/zigman/3870025/realtime” published on May 30, 2015, Marketwatch.com published: “Conformis shares plunge more than 30% on cut outlook, CEO search” on May 12, 2016. More interesting news about ConforMIS Inc (NASDAQ:CFMS) were released by: Quotes.Wsj.com and their article: “ConforMIS Inc. CFMS (US: Nasdaq)” published on June 30, 2015 as well as Bostonglobe.com‘s news article titled: “ConforMIS taking a custom-fit approach to joint replacements” with publication date: August 18, 2015.
CFMS Company Profile
ConforMIS, Inc., incorporated on March 26, 2004, is a medical technology firm that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped. The Company’s products include iTotal, iTotal PS, iDuo and iUni. The Company’s iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. iFit Design is the Company’s algorithms and computer software that it uses to design customized implants and associated single-use, patient-specific instrumentation, which is referred to as iJigs. iJigs is based on a computed tomography (CT) scan of the patient and to prepare a surgical plan customized for the patient that it calls iView. iFit Printing is a three-dimensional (3D) printing technology that the Company uses to manufacture iJigs. iFit Just-in-Time Delivery is its just-in-time manufacturing and delivery capability. The Firm markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore and Hong Kong.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.